HMGB1 and Sepsis: Anti-HMGB1 antibody treatment and specific inhibition of DC secretion of HMGB1 by small interfering RNA (siRNA) of HMGB1 significantly reduce sepsis-induced mortality, which may provide a treatment strategy for sepsis [178, 179].